Respiratory Syncytial Virus (RSV) Infection

Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Vaxart
VaxartSOUTH SAN FRANCISCO, CA
1 program
1
BTA-C585 oral capsulePhase 21 trial
Active Trials
NCT02718937CompletedEst. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
VaxartBTA-C585 oral capsule

Clinical Trials (1)

NCT02718937VaxartBTA-C585 oral capsule

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Start: Mar 2016Est. completion: Dec 2016
Phase 2Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space